Benjamin Cravatt
CIK: 0001819573
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ALNY
ALNYLAM PHARMACEUTICALS, INC.
Director
Discretionary Trading P&L
Holdings
About Cravatt Benjamin
Cravatt Benjamin (SEC CIK 0001819573) files insider reports with the SEC as Director of ALNYLAM PHARMACEUTICALS, INC. (ALNY).
Signal8 holds 2 ownership filings by Cravatt Benjamin (1 Form 3, 1 Form 4), filed on Jun 3, 2026. Those filings report 1 transaction, the latest on Jun 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Cravatt Benjamin's filings is in CAMBRIDGE, MA.
Recent filings by Cravatt Benjamin
- Jun 1, 2026: Grant or award of ALNY derivative securities (Form 4, code A).
Other insiders filing for ALNYLAM PHARMACEUTICALS, INC. (ALNY)
- SUPRAN BRYAN, EVP, CLO and Secretary
- Greenstreet Yvonne, Chief Executive Officer
- PYOTT DAVID E I, Director
- Sigal Charles Elliott, Director
- SCHULMAN AMY W, Director
- Reitan Colleen F, Director